Alcohol Withdrawal Syndrome: Outpatient Management

The up-regulation of dopaminergic and noradrenergic pathways could be responsible for the development, respectively, of hallucinations and of autonomic hyperactivity during AWS [6]. During alcohol withdrawal, you may experience a spike in blood pressure, which clonidine will address. Clonidine may also relax your body and relieve pain throughout the withdrawal process. Their recommendations are the result of expert consensus and do not incorporate formal processes such as GRADE methodology. The topics reviewed are not comprehensive for the topic of alcohol withdrawal but were specifically selected to be practical for the bedside intensivist.

  1. If you are otherwise healthy, have the support of family or friends, and have a stable home life, you will probably do well with outpatient treatment.
  2. At the prescribed doses, there have not been any reports of euphoria or other pleasant effects caused by the drug.
  3. The reason for the recalled batches was not a problem with the efficacy of the drug but rather a problem with Catapres production.
  4. The identification and subsequent treatment of AWS is of paramount clinical importance, given that AWS is one of the causes of preventable morbidity and mortality [8].
  5. The topics reviewed are not comprehensive for the topic of alcohol withdrawal but were specifically selected to be practical for the bedside intensivist.

Some researchers believe clonidine’s mechanism of action in the brain is what makes it able to treat withdrawal symptoms. During opioid withdrawal, neurotransmitters (chemicals) that excite the brain often increase. https://sober-home.org/ Clonidine is different from some other medications used for medication-assisted treatment (MAT). While it’s generally not seen as highly addictive, there is a possibility of developing dependence.

These include carbamazepine, valproate, sodium oxybate, baclofen, gabapentin, and topiramate. Sodium Oxybate (SMO) also called gamma-hydroxybutyric acid is a short-chain fatty acid that occurs naturally in mammalian brain, in particular in the thalamus, hypothalamus and basal ganglia. SMO is structurally similar to the inhibitory neurotransmitter GABA, binding to SMO and GABAB receptors with high and low affinity, respectively [83].

Empiric prophylaxis for alcohol withdrawal is beneficial and has been shown to decrease complications from alcohol withdrawal for patients at risk for severe or complicated AWS. Clonidine also has demonstrated effectiveness in relieving alcohol withdrawal symptoms. However, it is not broadly thought of as a first-line treatment option for alcohol withdrawal. This is because alcohol withdrawal and opioid withdrawal cause similar changes in the brain. Clonidine prevents neurotransmitters from releasing noradrenergic chemicals into the brain.

Buprenorphine and methadone are often given as first-choice therapy for opioid detox and withdrawal. The main difference between clonidine and these medications is that clonidine is less effective. Methadone, buprenorphine and similar medications work on the opioid receptors in the brain. In contrast, clonidine works by blocking noradrenergic neurotransmitters in the brain.

How is alcohol withdrawal diagnosed?

Potential of clonidine in the treatment of alcohol withdrawal reactions was investigated. Clonidine was found to be remarkably effective in alleviating various alcohol sober living boston abstinence signs in a chronic alcoholic. The usefulness of clonidine and related alpha 2-agonists in the treatment of alcohol withdrawal states is discussed.

These effects are mediated by the increase (orupregulation) of GABA.35 The inherent pharmacologic effects of phenobarbital have led clinicians tofurther investigate its place in therapy for the treatment of AWS. However, limiteddata provided by small and insufficiently powered studies leave this clinicalquestion unanswered. When getting AWS treatment as an outpatient, you will still have medical care, such as regular appointments with your treatment team and therapy sessions, but you will return home at night.

Treatment of Severe Alcohol Withdrawal: A Focus on Adjunctive

Signs and symptoms of alcohol withdrawal syndrome, divided per stage [60, 74]. Table 1 provides a summary of prospective, randomized clinical trials of clonidine for treatment of alcohol withdrawal. While benzodiazepine may be the most common and effective medication for treating AWS, clonidine can also play a critical role in the process. In most cases, you can safely take it along with benzodiazepines in a medically prescribed regimen during alcohol withdrawal.

Role of α2-agonists in the Treatment of Acute Alcohol Withdrawal

Inpatient treatment for alcohol withdrawal syndrome provides clients with 24-hour supervision, treatment, and assistance throughout the difficult detox period. Especially in cases of long-term alcohol use, a history of seizures, or repeated attempts at alcohol withdrawal, inpatient care may be the best option. Signs of alcohol withdrawal syndrome may appear just a few hours after a client quits drinking. More severe symptoms start within the first 24 hours of a person’s last drink. Therefore, prompt treatment with prescription medication is crucial in managing these symptoms.

Management and Treatment

While not as common as opioid or amphetamine addiction, clonidine addiction may occur. As a drug with fewer restrictions than opioids, clonidine is not as difficult to obtain and therefore more available in non-prescription settings. Those who are trying to become pregnant, are pregnant, or are nursing should avoid taking clonidine. Although there is little data showing any adverse effects on an embryo or infant, there is also a lack of positive evidence.

It is important to trust the judgment of your medical professionals to prescribe the medications that will be most effective for your individual situation. Clonidine is an alpha-2 agonist with similarities to epinephrine, methoxamine, and pseudoephedrine. Alpha-2 agonist drugs work in different ways to relieve specific issues, such as pressure on the eyes, blood vessel constriction, sinus congestion, and shock. Phenobarbital is a safe and effective pharmacologic agent for use in prevention and treatment of AWS. A fixed-dose approach is recommended due to the pharmacokinetics and long half-life of phenobarbital. In this section, we define primary prevention and treatment medications as the preferred agents for initial prophylaxis or treatment of AWS, with no recommendation as to best agent within these medications.